Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertaseSTRUNK, R. C; WEBSTER, R. O.Molecular immunology. 1985, Vol 22, Num 1, pp 37-43, issn 0161-5890Article

Nomenclature for human complement factor B*GESERICK, G; ABBAL, M; SIEMENS, I et al.European journal of immunogenetics. 1993, Vol 20, Num 4, pp 307-309, issn 0960-7420Article

Complement activation according to the alternate pathway by glass and plastic surfaces and its role in neutrophil adhesionHED, J; JOHANSSON, M; LINDROTH, M et al.Immunology letters. 1984, Vol 8, Num 6, pp 295-299, issn 0165-2478Article

A reexamination of the role of magnesium in the human alternative pathway of complementPRYZDIAL, E. L. G; ISENMAN, D. E.Molecular immunology. 1986, Vol 23, Num 1, pp 87-96, issn 0161-5890Article

Expression of complement components of the alternative pathway by glioma cell linesGASQUE, P; JULEN, N; ISCHENKO, A. M et al.The Journal of immunology (1950). 1992, Vol 149, Num 4, pp 1381-1387, issn 0022-1767Article

Inhibition by lysine and arginine of the conversion of C3 and B in the serum and a purified systemSHIRAHAMA, S; SUGAWARA, Y; TAKADA, Y et al.International journal of immunopharmacology. 1986, Vol 8, Num 3, pp 269-276, issn 0192-0561Article

ACTIVITY OF THE ALTERNATIVE PATHWAY OF COMPLEMENT IN THE NEWBORN INFANTADAMKIN D; STITZEL A; URMSON J et al.1978; J. PEDIATR.; USA; DA. 1978; VOL. 93; NO 4; PP. 604-608; BIBL. 24 REF.Article

The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activationBIRD, P; LACHMANN, P. J.European journal of immunology. 1988, Vol 18, Num 8, pp 1217-1222, issn 0014-2980Article

Activation of the alternative complement pathway: clinical application of a new technique to measure fragment BaSENALDI, G; PEAKMAN, M; ALHAQ, A et al.Journal of clinical pathology. 1987, Vol 40, Num 10, pp 1235-1239, issn 0021-9746Article

Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitroMOLLNES, T. E; NG, Y. C; PETERS, D. K et al.Clinical and experimental immunology (Print). 1986, Vol 65, Num 1, pp 73-79, issn 0009-9104Article

Inhibition of the classical activation pathway of complement-mediated lysis by monoclonal antibodies to complement components C3c and C3dMUSHENS, R. E; BAKACS, T.Transfusion (Philadelphia, PA). 1992, Vol 32, Num 5, pp 430-434, issn 0041-1132Conference Paper

Influence of factor D concentrations on fluid phase C3 activation, lysis of rabbit erythrocytes and solubilization of immune complexesSTURFELT, G; SJÖHOLM, A. G; TRUEDSSON, L et al.Immunology letters. 1989, Vol 20, Num 3, pp 231-236, issn 0165-2478, 6 p.Article

A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptidesLAMBRIS, J. D; AVILA, D; BECHERER, J. D et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 24, pp 12147-12150, issn 0021-9258Article

C3 nephritic factor protects bound C3bBb from cleavage by factor I and human erythrocytesMOLD, C; MEDOF, M. E.Molecular immunology. 1985, Vol 22, Num 5, pp 507-512, issn 0161-5890Article

Species specificity of recognition by the alternative pathway of complementHORSTMANN, R. D; PANGBURN, M. K; MÜLLER-EBERHARD, H. J et al.The Journal of immunology (1950). 1985, Vol 134, Num 2, pp 1101-1104, issn 0022-1767Article

Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfacesWASHBURN, R. G; BRYANT-VARELA, B. J; JULIAN, N. C et al.Molecular immunology. 1991, Vol 28, Num 4-5, pp 465-470, issn 0161-5890, 6 p.Article

Genetic, structural, and functional studies of a C3-like protein in the marsupial Setonix brachyurusLYNCH, D. M; ASHMAN, R. B; KAY, P. H et al.Experimental and clinical immunogenetics. 1993, Vol 10, Num 4, pp 195-201, issn 0254-9670Article

Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoidsDAUCHEL, H; JULEN, N; LEMERCIER, C et al.European journal of immunology. 1990, Vol 20, Num 8, pp 1669-1675, issn 0014-2980, 7 p.Article

Soluble C3 proconvertase and convertase of the classical pathway of human complement: conditions of stabilization in vitroVILLIERS, M.-B; THIELENS, N. M; COLOMB, M. G et al.Biochemical journal (London. 1906). 1985, Vol 226, Num 2, pp 429-436, issn 0006-2936Article

Differential expression of complement components in human fetal and adult kidneysTIMMERMAN, J. J; VAN DER WOUDE, F. J; VAN GIJLSWIJK-JANSSEN, D. J et al.Kidney international. 1996, Vol 49, Num 3, pp 730-740, issn 0085-2538Conference Paper

INACTIVATOR OF THE THIRD COMPONENT OF COMPLEMENT AS AN INHIBITOR IN THE PROPERDIN PATHWAYALPER CA; ROSEN FS; LACHMANN PJ et al.1972; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1972; VOL. 69; NO 10; PP. 2910-2913; BIBL. 20 REF.Serial Issue

THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION. THE ROLE OF C3 AND ITS INACTIVATOR (KAF)NICOL PAE; LACHMANN PJ.1973; IMMUNOLOGY; G.B.; DA. 1973; VOL. 24; NO 2; PP. 259-275; BIBL. 1 P.1/2Serial Issue

Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeaeDENSEN, P; MCRILL, C. M; ROSS, S. C et al.The Journal of immunology (1950). 1988, Vol 141, Num 11, pp 3902-3909, issn 0022-1767Article

Monoclonal anti-human C3d antibodies: stabilization of the alternative pathway C3 convertaseTANUMA, Y; OHI, H; HATANO, M et al.Immunology (Oxford). 1989, Vol 68, Num 4, pp 445-448, issn 0019-2805Article

A complement-resistant HeLa cell line (T638) is blocked at the step of C3 depositionSANTI, P; JOINER, K. A; HAMMER, C. H et al.The Journal of immunology (1950). 1987, Vol 138, Num 10, pp 3385-3391, issn 0022-1767Article